Illexcor Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$13M
- Investors
-
4
Illexcor Therapeutics General Information
Description
Operator of a biopharmaceutical company intended for the discovery and development of innovative oral therapies for sickle cell disease. The company develops oral Hemoglobin S polymerization inhibitors that can provide profound disease-modifying clinical benefits for sickle cell disease, enabling patients living with hematologic diseases to improve their lives and provide effective and disease-modifying treatments.
Contact Information
Website
www.illexcor.comCorporate Office
- 11924 Evening Loop
- Henrico, VA 23233
- United States
Corporate Office
- 11924 Evening Loop
- Henrico, VA 23233
- United States
Illexcor Therapeutics Timeline
Illexcor Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 07-May-2026 | $13M | Completed | Startup | ||
| 7. Seed Round | 12-Mar-2025 | Completed | Startup | |||
| 6. Grant | 01-Jan-2025 | Completed | Startup | |||
| 5. Grant | 01-Jan-2024 | Completed | Startup | |||
| 4. Grant | 01-Jan-2023 | Completed | Startup | |||
| 3. Grant | 01-Jan-2023 | Completed | Startup | |||
| 2. Grant | 01-Jan-2021 | $298K | Completed | Startup | ||
| 1. Grant | 01-Jan-2020 | $600K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Illexcor Therapeutics Signals
Illexcor Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Janus Henderson Investors | Asset Manager | Minority | ||
| Zynext Ventures | Corporate Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| National Institutes of Health | Government |
Illexcor Therapeutics FAQs
-
When was Illexcor Therapeutics founded?
Illexcor Therapeutics was founded in 2020.
-
Where is Illexcor Therapeutics headquartered?
Illexcor Therapeutics is headquartered in Henrico, VA.
-
What is the size of Illexcor Therapeutics?
Illexcor Therapeutics has 7 total employees.
-
What industry is Illexcor Therapeutics in?
Illexcor Therapeutics’s primary industry is Drug Discovery.
-
Is Illexcor Therapeutics a private or public company?
Illexcor Therapeutics is a Private company.
-
What is Illexcor Therapeutics’s current revenue?
The current revenue for Illexcor Therapeutics is .
-
How much funding has Illexcor Therapeutics raised over time?
Illexcor Therapeutics has raised $13M.
-
Who are Illexcor Therapeutics’s investors?
Janus Henderson Investors, Zynext Ventures, U.S. Department of Health and Human Services, and National Institutes of Health have invested in Illexcor Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process